[A POEMS syndrome revealed by a blue toe syndrome]

Rev Med Interne. 2018 Feb;39(2):127-129. doi: 10.1016/j.revmed.2017.09.005. Epub 2017 Dec 26.
[Article in French]

Abstract

Introduction: Arterial and venous thromboses occur in almost one in five patients with POEMS syndrome and usually in macrocirculation.

Case report: We report a 67-year-old male with a POEMS syndrome who presented initially with a blue toe syndrome. He complained of Raynaud's syndrome and left foot paresthesia. Physical examination showed gynecomastia, lymphadenopathies and skin lesions. Cardiovascular investigations excluded atrial fibrillation, unstable atherosclerotic lesions and vascular calcifications. Imaging studies showed diffuse osteosclerotic lesions. Monoclonal protein with lambda light chain was discovered and serum level of VEGF was increased at 2900pg/ml.

Conclusion: This is to our knowledge the first case of thrombotic microangiopathy in POEMS syndrome without embolic cause or calciphylaxis.

Keywords: Blue toe syndrome; Microangiopathie; Microangiopathy; POEMS syndrome; Syndrome POEMS; Syndrome des orteils bleus; VEGF.

Publication types

  • Case Reports

MeSH terms

  • Aged
  • Antineoplastic Agents, Alkylating / therapeutic use
  • Blue Toe Syndrome / diagnosis
  • Blue Toe Syndrome / drug therapy
  • Blue Toe Syndrome / etiology*
  • Dexamethasone / therapeutic use
  • Glucocorticoids / therapeutic use
  • Humans
  • Male
  • Melphalan / therapeutic use
  • POEMS Syndrome / complications*
  • POEMS Syndrome / diagnosis
  • POEMS Syndrome / drug therapy
  • Positron-Emission Tomography
  • Tomography, X-Ray Computed
  • Vascular Endothelial Growth Factor A / blood

Substances

  • Antineoplastic Agents, Alkylating
  • Glucocorticoids
  • VEGFA protein, human
  • Vascular Endothelial Growth Factor A
  • Dexamethasone
  • Melphalan